Shares of AmerisourceBergen Co. (NYSE: ABC – Get Rating) have been assigned a consensus recommendation of “Buy” from the fourteen research firms that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $ 169.82.
A number of research firms recently weighed in on ABC. Argus increased their price target on AmerisourceBergen from $ 140.00 to $ 160.00 in a research note on Monday, March 14th. StockNews.com raised shares of AmerisourceBergen from a “buy” rating to a “strong-buy” rating in a report on Friday, May 6th. Mizuho lifted their price target on shares of AmerisourceBergen from $ 139.00 to $ 162.00 in a report on Thursday, May 5th. Morgan Stanley lowered their price objective on shares of AmerisourceBergen from $ 178.00 to $ 175.00 and set an “equal weight” rating for the company in a research report on Friday, May 27th. Finally, Cowen cut their target price on shares of AmerisourceBergen from $ 171.00 to $ 170.00 and set an “outperform” rating on the stock in a research report on Thursday, June 9th.
In related news, CEO Steven H. Collis sold 11,480 shares of the company stock in a transaction that occurred on Tuesday, April 12th. The shares were sold at an average price of $ 162.11, for a total transaction of $ 1,861,022.80. Following the sale, the chief executive officer now owns 205,178 shares of the company stock, valued at approximately $ 33,261,405.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Gina Clark sold 43,704 shares of the firm’s stock in a transaction on Monday, March 28th. The shares were sold at an average price of $ 153.71, for a total transaction of $ 6,717,741.84. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,060,079 shares of company stock worth $ 909,361,965. Corporate insiders own 28.80% of the company stock.
Large investors have recently bought and sold shares of the stock. Bank of America Corp DE increased its stake in AmerisourceBergen by 47.9% in the 1st quarter. Bank of America Corp DE now owns 1,546,732 shares of the company stock worth $ 239,294,000 after acquiring an additional 500,599 shares during the last quarter. Insight Advisors LLC PA purchased a new position in shares of AmerisourceBergen during the first quarter worth about $ 227,000. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of AmerisourceBergen by 25.9% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 21,808 shares of the company stock worth $ 3,374,000 after purchasing an additional 4,482 shares in the last quarter. Walleye Capital LLC increased its position in shares of AmerisourceBergen by 52.9% in the first quarter. Walleye Capital LLC now owns 38,219 shares of the company stock worth $ 5,913,000 after purchasing an additional 13,225 shares during the last quarter. Finally, Kestra Private Wealth Services LLC raised its stake in AmerisourceBergen by 41.8% in the first quarter. Kestra Private Wealth Services LLC now owns 4,590 shares of the company stock valued at $ 710,000 after purchasing an additional 1,354 shares in the last quarter. 64.17% of the stock is owned by institutional investors.
ABC opened at $ 141.52 on Thursday. The stock has a market capitalization of $ 29.64 billion, a P / E ratio of 17.26, a P / E / G ratio of 1.64 and a beta of 0.45. The company has a current ratio of 0.92, a quick ratio of 0.56 and a debt-to-equity ratio of 5.13. AmerisourceBergen has a 12 month low of $ 111.34 and a 12 month high of $ 167.19. The firm’s fifty day simple moving average is $ 155.35 and its 200 day simple moving average is $ 143.45.
AmerisourceBergen (NYSE: ABC – Get Rating) last issued its quarterly earnings results on Wednesday, May 4th. The company reported $ 3.22 EPS for the quarter, beating analysts’ consensus estimates of $ 2.99 by $ 0.23. The company had revenue of $ 57.72 billion for the quarter, compared to analyst estimates of $ 57.26 billion. AmerisourceBergen had a return on equity of 349.46% and a net margin of 0.75%. The company quarterly revenue was up 17.4% compared to the same quarter last year. During the same period in the previous year, the company posted $ 2.53 earnings per share. On average, equities research analysts predict that AmerisourceBergen will post 10.95 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, May 31st. Stockholders of record on Monday, May 16th were given a dividend of $ 0.46 per share. The ex-dividend date was Friday, May 13th. This represents a $ 1.84 dividend on an annualized basis and a dividend yield of 1.30%. AmerisourceBergen’s dividend payout ratio (DPR) is presently 22.44%.
AmerisourceBergen Company Profile: (Get Rating)
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
Receive News & Ratings for AmerisourceBergen Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for AmerisourceBergen and related companies with MarketBeat.com’s FREE daily email newsletter.